Anti‐myelin antibodies in multiple sclerosis: clinically useful?

od Polman, C H, Killestein, J
Izdano 2006

Drug treatment of multiple sclerosis

od Polman, C H, Uitdehaag, B M J
Izdano 2000

Magnetic resonance imaging studies in multiple sclerosis twins.

od Uitdehaag, B M, Polman, C H, Valk, J, Koetsier, J C, Lucas, C J
Izdano 1989

Diffusely Abnormal White Matter in Progressive Multiple Sclerosis: In Vivo Quantitative MR Imaging Characterization and Comparison between Disease Types

od Vrenken, H., Seewann, A., Knol, D.L., Polman, C.H., Barkhof, F., Geurts, J.J.G.
izdano v AJNR Am J Neuroradiol (2010)

Treatment with depleting CD4 monoclonal antibody results in a preferential loss of circulating naive T cells but does not affect IFN-gamma secreting TH1 cells in humans.

od Rep, M. H., van Oosten, B. W., Roos, M. T., Adèr, H. J., Polman, C. H., van Lier, R. A.
Izdano 1997

No evidence of misdiagnosis in patients with multiple sclerosis and repeated positive anticardiolipin antibody testing based on magnetic resonance imaging and long term follow‐up

od Liedorp, M, Sanchez, E, van Hoogstraten, I M W, von Blomberg, B M E, Barkhof, F, Polman, C H
Izdano 2007

Normal-Appearing White Matter Changes Vary with Distance to Lesions in Multiple Sclerosis

od Vrenken, H., Geurts, J.J.G., Knol, D.L., Polman, C.H., Castelijns, J.A., Pouwels, P.J.W., Barkhof, F.
izdano v AJNR Am J Neuroradiol (2006)

Cognition in MS correlates with resting-state oscillatory brain activity: An explorative MEG source-space study()

od Van der Meer, M.L., Tewarie, P., Schoonheim, M.M., Douw, L., Barkhof, F., Polman, C.H., Stam, C.J., Hillebrand, A.
Izdano 2013

Axon loss is an important determinant of weakness in multifocal motor neuropathy

od Van Asseldonk, J T H, Van den Berg, L H, Kalmijn, S, Van den Berg‐Vos, R M, Polman, C H, Wokke, J H J, Franssen, H
Izdano 2006

Proxy measurements in multiple sclerosis: agreement between patients and their partners on the impact of multiple sclerosis in daily life

od van der Linden, F A H, Kragt, J J, Hobart, J C, Klein, M, Thompson, A J, van der Ploeg, H M, Polman, C H, Uitdehaag, B M J
Izdano 2006

Long-term impact of interferon beta-1b in patients with CIS: 8-year follow-up of BENEFIT

od Edan, G, Kappos, L, Montalbán, X, Polman, C H, Freedman, M S, Hartung, H-P, Miller, D, Barkhof, F, Herrmann, J, Lanius, V, Stemper, B, Pohl, C, Sandbrink, R, Pleimes, D
Izdano 2014

Sample sizes for brain atrophy outcomes in trials for secondary progressive multiple sclerosis

od Altmann, D R., Jasperse, B, Barkhof, F, Beckmann, K, Filippi, M, Kappos, L D., Molyneux, P, Polman, C H., Pozzilli, C, Thompson, A J., Wagner, K, Yousry, T A., Miller, D H.
Izdano 2009

White Matter Diffusion Changes during the First Year of Natalizumab Treatment in Relapsing-Remitting Multiple Sclerosis

od Wiebenga, O.T., Schoonheim, M.M., Hulst, H.E., Nagtegaal, G.J.A., Strijbis, E.M.M., Steenwijk, M.D., Polman, C.H., Pouwels, P.J.W., Barkhof, F., Geurts, J.J.G.
izdano v AJNR Am J Neuroradiol (2016)

Enhanced Axonal Metabolism during Early Natalizumab Treatment in Relapsing-Remitting Multiple Sclerosis

od Wiebenga, O.T., Klauser, A.M., Schoonheim, M.M., Nagtegaal, G.J.A., Steenwijk, M.D., van Rossum, J.A., Polman, C.H., Barkhof, F., Pouwels, P.J.W., Geurts, J.J.G.
izdano v AJNR Am J Neuroradiol (2015)

Cerebral atrophy as outcome measure in short-term phase 2 clinical trials in multiple sclerosis

od van den Elskamp, I. J., Boden, B., Dattola, V., Knol, D. L., Filippi, M., Kappos, L., Fazekas, F., Wagner, K., Pohl, C., Sandbrink, R., Polman, C. H., Uitdehaag, B. M. J., Barkhof, F.
Izdano 2010

Genetic Correlations of Brain Lesion Distribution in Multiple Sclerosis: An Exploratory Study

od Sombekke, M.H., Vellinga, M.M., Uitdehaag, B.M.J., Barkhof, F., Polman, C.H., Arteta, D., Tejedor, D., Martinez, A., Crusius, J.B.A., Peña, A.S., Geurts, J.J.G., Vrenken, H.
izdano v AJNR Am J Neuroradiol (2011)

A search for new MRI criteria for dissemination in space in subjects with a clinically isolated syndrome

od Korteweg, T., Tintore, M., Uitdehaag, B. M. J., Knol, D. L., Vrenken, H., Rovira, A., Frederiksen, J., Miller, D. H., Fernando, K., Filippi, M., Agosta, F., Rocca, M. A., Fazekas, F., Enzinger, C., Parry, A., Polman, C. H., Montalban, X., Barkhof, F.
Izdano 2009

Multicontrast MR Imaging at 7T in Multiple Sclerosis: Highest Lesion Detection in Cortical Gray Matter with 3D-FLAIR

od Kilsdonk, I.D., de Graaf, W.L., Soriano, A. Lopez, Zwanenburg, J.J., Visser, F., Kuijer, J.P.A., Geurts, J.J.G., Pouwels, P.J.W., Polman, C.H., Castelijns, J.A., Luijten, P.R., Barkhof, F., Wattjes, M.P.
izdano v AJNR Am J Neuroradiol (2013)